Matthew Cavender, MD
Interventional Cardiology · Chapel Hill, NCNPI 1841492402
Payments from drug & device makers
Across 594 payments — averaging $2607.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$300K
- CSL Behring$262K
- Novo Nordisk AS$227K
- Amgen$194K
- Janssen Research & Development, LLC$106K
- Boehringer Ingelheim International GmbH$95K
- plus $365K from 25 others
Across 59 payments — averaging $2986.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$162K
- Novo Nordisk$14K
- Amgen$413
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 7 | $299,653 |
| CSL Behring | 96 | $262,171 |
| Novo Nordisk AS | 51 | $227,015 |
| Amgen | 35 | $194,239 |
| Janssen Research & Development, LLC | 44 | $106,014 |
| Boehringer Ingelheim International GmbH | 12 | $95,235 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 5 | $94,338 |
| Cleerly, Inc. | 8 | $57,927 |
| Bayer | 46 | $51,605 |
| Novo Nordisk | 36 | $40,018 |
| Merck | 31 | $33,986 |
| Edwards Lifesciences | 106 | $22,771 |
| AbbVie | 18 | $17,886 |
| Eli Lilly | 4 | $13,200 |
| E.r. Squibb & Sons, L.L.C. | 2 | $8,083 |
| Medtronic | 13 | $7,680 |
| Corcept Therapeutics | 10 | $5,389 |
| AstraZeneca | 2 | $3,880 |
| Boston Scientific | 10 | $2,459 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $2,344 |
| Abbott | 17 | $954 |
| Astrazeneca UK Limited | 3 | $867 |
| Boehringer Ingelheim | 6 | $720 |
| Inari Medical, Inc. | 6 | $129 |
| Biosense Webster, Inc. | 2 | $123 |
| Chiesi USA, Inc. | 1 | $84 |
| Abiomed | 2 | $78 |
| Pfizer | 1 | $67 |
| GE HealthCare | 1 | $44 |
| Philips North America LLC | 1 | $14 |
| Angiodynamics, Inc. | 1 | $12 |
How this compares
$1,548,986 in reported general payments places this provider in the 95th percentile of 180 interventional cardiology providers in North Carolina.
See all interventional cardiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Chapel Hill
- John VavalleChapel Hill$746K
- Ravish SacharRaleigh$10.1M
- George AdamsGarner$5.2M
- Paul MahoneyGreenville$3.9M
- Oluseun AlliCharlotte$2.3M
- Patrick SimpsonPinehurst$1.6M
- Rajesh SwaminathanDurham$1.4M
- Steven FilbyPinehurst$1.3M
- John PasquiniCharlotte$1.3M
- James ZidarRaleigh$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.